📂 Drugs
mRNA-1273.214 vaccine — Definition
mRNA-1273.214 aşısı / mRNA-1273.214 vaccine
Developed by modern, the original SARS-CoV-2 virus and a bivalan vaccine targeting the spike protein against the Beta variant. This vaccine is designed to increase immune response to both the original strain of COVID-19 and alarming variants. In clinical use, it is especially applied as a booster dose against variants and provides additional protection in those who have weakened immunity.
Frequently Asked Questions
❓ What is mRNA-1273.214 aşısı?
mRNA-1273.214 aşısı; developed by modern, the original SARS-CoV-2 virus and a bivalan vaccine targeting the spike protein against the Beta variant. This vaccine is designed to increase immune response to both the original strain of COVID-19 and alarming variants. In clinical use, it is especially applied as a booster dose against variants and provides additional protection in those who have weakened immunity.
❓ What is mRNA-1273.214 vaccine in Turkish?
The Turkish equivalent of "mRNA-1273.214 vaccine" is mRNA-1273.214 aşısı.
❓ Which medical field is mRNA-1273.214 aşısı related to?
This term belongs to the Drugs category.